Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$29.75 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources Display this book on your site! Related Titles Perspectives on Biomarker and Surrogate Endpoint Evaluation:Discussion Forum Summary Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease Other Related Titles Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment: The State of the Science, Evaluation, Implementation, and Economics - Workshop Summary (2006) National Cancer Policy Forum (NCPF) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Acronyms." Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment: The State of the Science, Evaluation, Implementation, and Economics - Workshop Summary. Washington, DC: The National Academies Press, 2006. Please select a format: Page 85   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. ACRONYMS ASCO American Society of Clinical Oncology ASR Analyte-Specific Reagent CAP College of American Pathologists CMS Centers for Medicare & Medicaid Services CLIA Clinical Laboratory Improvement Amendment CPT Current Procedural Terminology EGAPP Evaluation of Genomic Applications in Practice and Prevention EGF Epidermal Growth Factor EGFR Epidermal Growth Factor Receptor FDA Food and Drug Administration FISH Fluorescent In Situ Hybridization HER2 Human Epidermal Growth Factor Receptor 2 HIPAA Health Insurance Portability and Accountability Act IHC Immunohistochemistry IVD In Vitro Diagnostic LOH Loss of Heterozygosity mRNA Messenger Ribonucleic Acid MIAME Minimum Information About a Microarray Experiment NBN National Biospecimen Network NCCN National Comprehensive Cancer Network NCI National Cancer Institute NICE National Institute for Health and Clinical Excellence (of the United Kingdom) NIH National Institutes of Health (of the United States) PET Positron Emission Tomography PMA Premarket Approval PSA Prostate-Specific Antigen QALY Quality-Adjusted Life-Year SNP Single Nucleotide Polymorphism SOP Standard Operating Procedure SPORE Specialized Programs of Research Excellence TEC Technology Evaluation Center (of BlueCross BlueShield) USPSTF United States Preventive Services Task Force Page 85 Front Matter (R1-R10) Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment (1-84) Acronyms (85-85) Glossary (86-91) References (92-92) Appendix A Workshop Agenda (93-98) Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants (99-102)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 85
Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment: The State of the Science, Evaluation, Implementation, and Economics ACRONYMS ASCO American Society of Clinical Oncology ASR Analyte-Specific Reagent CAP College of American Pathologists CMS Centers for Medicare & Medicaid Services CLIA Clinical Laboratory Improvement Amendment CPT Current Procedural Terminology EGAPP Evaluation of Genomic Applications in Practice and Prevention EGF Epidermal Growth Factor EGFR Epidermal Growth Factor Receptor FDA Food and Drug Administration FISH Fluorescent In Situ Hybridization HER2 Human Epidermal Growth Factor Receptor 2 HIPAA Health Insurance Portability and Accountability Act IHC Immunohistochemistry IVD In Vitro Diagnostic LOH Loss of Heterozygosity mRNA Messenger Ribonucleic Acid MIAME Minimum Information About a Microarray Experiment NBN National Biospecimen Network NCCN National Comprehensive Cancer Network NCI National Cancer Institute NICE National Institute for Health and Clinical Excellence (of the United Kingdom) NIH National Institutes of Health (of the United States) PET Positron Emission Tomography PMA Premarket Approval PSA Prostate-Specific Antigen QALY Quality-Adjusted Life-Year SNP Single Nucleotide Polymorphism SOP Standard Operating Procedure SPORE Specialized Programs of Research Excellence TEC Technology Evaluation Center (of BlueCross BlueShield) USPSTF United States Preventive Services Task Force

Representative terms from entire chapter:

epidermal growth